Review of new biological drugs and JAK inhibitors approved for children and adolescents with moderate to severe atopic dermatitis: the situation in Uruguay. (2026). Archives of Pediatrics of Uruguay, 97(1), e801. https://doi.org/10.31134/AP.97.1.20